Skip to main content

BAHL & GAYNOR INC

Position in NVS — Novartis AG

CIK 872259 CINCINNATI, OH

Position in NVS

as of Mar 31, 2026 · filed May 7, 2026
Position Value
$13,088,842
+$1,209,688 QoQ
Shares Held
85,688
-0.6% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

BAHL & GAYNOR INC holds $1,357,498,569 across 6 Drug Manufacturers - General names.

# Ticker Company Shares Value (USD) Open

All Filings in NVS

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $13,088,842 85,688
2025-12-31 $11,879,154 86,162
2025-09-30 $11,212,151 87,431
2025-06-30 $11,089,235 91,639
2025-03-31 $10,429,399 93,554
2024-12-31 $9,633,787 99,001
2024-09-30 $11,337,751 98,572
2024-06-30 $10,879,679 102,195
2024-03-31 $9,964,157 103,010
2023-12-31 $10,482,503 103,818
2023-09-30 $10,602,505 104,089
2023-06-30 $10,727,540 106,308
2023-03-31 $9,780,060 106,305
2022-12-31 $9,752,490 107,501
2022-09-30 $8,118,096 106,803
2022-06-30 $9,671,330 114,413
2022-03-31 $10,695,233 121,883
2021-12-31 $11,544,378 131,981
2021-09-30 $11,415,179 139,584
2021-06-30 $12,880,898 141,176
2021-03-31 $13,711,846 160,410
2020-12-31 $15,370,371 162,770
2020-09-30 $14,347,008 164,984
2020-06-30 $14,861,861 170,161
2020-03-31 $14,390,328 174,534